MECHANISMS OF ALLERGIC SENSITIZATION BY NITROGEN DIOXIDE EXPOSURE

二氧化氮暴露引起过敏的机制

基本信息

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Asthma is a disease characterized by the presence of immune cells, which are capable of damaging the lungs and contributing to the breathing difficulty of patients. One molecule formed by these immune cells is the toxic gas, nitrogen dioxide (NO2), more commonly known as an air pollutant. It is completely unclear whether NO2 contributes to asthma and how it acts on the lung. Since lung epithelial cells, which line the breathing tube, may come in contact with a considerable amount of NO2, and also are believed to play an important role in asthma, the focus of Project 3 is to examine the consequences of NO2-induced damage to the lung epithelial cells. We have designed experiments in intact mice, which can be exposed to NO2 via inhalation. Our objective is to test whether cell signaling events are important in the pathological response to NO2 inhalation and whether they may contribute to asthma exacerbation and sensitization. We have determined that NO2 inhalation causes damage to the lung epithelium and induces the release of intracellular molecules, which are normally sequestered away from recognition by cell surface receptors. Candidate receptors for these intracellular molecules are expressed by airway epithelium and induce intracellular signaling cascades when engaged by ligands. We are determining the role of these receptors, as well as intracellular signaling molecules, in the exacerbation of asthma in a mouse model by inhalation of NO2. To do so, we have obtained knockout mice from collaborators and are currently breeding sufficient numbers of mice for our studies. These studies will provide an important insights into the mechanisms by which toxic agents released by immune cells can cause damage to the lung, and may result in the development of drugs to prevent that damage from occurring.
这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者(PI)可能从另一个NIH来源获得了主要资金, 因此可以在其他CRISP条目中表示。所列机构为 研究中心,而研究中心不一定是研究者所在的机构。 哮喘是一种以免疫细胞的存在为特征的疾病,免疫细胞能够损害肺部并导致患者呼吸困难。由这些免疫细胞形成的一种分子是有毒气体,二氧化氮(NO2),通常被称为空气污染物。目前还不清楚NO2是否会导致哮喘,以及它如何作用于肺部。由于肺上皮细胞,内衬呼吸管,可能会接触到大量的NO2,也被认为是在哮喘中发挥重要作用,项目3的重点是检查NO2诱导的肺上皮细胞损伤的后果。 我们设计了完整的小鼠实验,可以通过吸入暴露于NO2。 我们的目的是测试细胞信号事件是否在NO2吸入的病理反应中是重要的,以及它们是否可能导致哮喘恶化和致敏。 我们已经确定,吸入NO2会导致肺上皮细胞损伤,并诱导细胞内分子的释放,这些分子通常被隔离,无法被细胞表面受体识别。 这些细胞内分子的候选受体由气道上皮表达,并且当被配体接合时诱导细胞内信号级联。 我们正在确定这些受体以及细胞内信号分子在吸入NO2的小鼠哮喘加重模型中的作用。 为此,我们从合作者那里获得了基因敲除小鼠,目前正在为我们的研究繁殖足够数量的小鼠。 这些研究将为免疫细胞释放的有毒物质对肺部造成损害的机制提供重要见解,并可能导致药物的开发,以防止这种损害的发生。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Matthew E Poynter其他文献

Are Biodiesel (B20) Emissions Less Harmful than Petrodiesel (B0)?
  • DOI:
    10.1016/j.freeradbiomed.2011.10.376
  • 发表时间:
    2011-11-01
  • 期刊:
  • 影响因子:
  • 作者:
    Muyao Li;Matthew E Poynter;Brian C Palmer;Erin Parker;Brooke T Mossman;Britt a Holmen;Naomi K Fukagawa
  • 通讯作者:
    Naomi K Fukagawa

Matthew E Poynter的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Matthew E Poynter', 18)}}的其他基金

Ketone Body Supplementation in Obese Asthma
肥胖性哮喘的酮体补充
  • 批准号:
    9905425
  • 财政年份:
    2018
  • 资助金额:
    $ 23.86万
  • 项目类别:
Serum Amyloid A3 in Allergic Asthma: An Endogenous Mediator of Disease Severity
过敏性哮喘中的血清淀粉样蛋白 A3:疾病严重程度的内源性介质
  • 批准号:
    8290627
  • 财政年份:
    2012
  • 资助金额:
    $ 23.86万
  • 项目类别:
Serum Amyloid A3 in Allergic Asthma: An Endogenous Mediator of Disease Severity
过敏性哮喘中的血清淀粉样蛋白 A3:疾病严重程度的内源性介质
  • 批准号:
    8616089
  • 财政年份:
    2012
  • 资助金额:
    $ 23.86万
  • 项目类别:
Serum Amyloid A3 in Allergic Asthma: An Endogenous Mediator of Disease Severity
过敏性哮喘中的血清淀粉样蛋白 A3:疾病严重程度的内源性介质
  • 批准号:
    8451381
  • 财政年份:
    2012
  • 资助金额:
    $ 23.86万
  • 项目类别:
Serum Amyloid A3 in Allergic Asthma: An Endogenous Mediator of Disease Severity
过敏性哮喘中的血清淀粉样蛋白 A3:疾病严重程度的内源性介质
  • 批准号:
    8802887
  • 财政年份:
    2012
  • 资助金额:
    $ 23.86万
  • 项目类别:
Nitrogen Dioxide in the Sensitization to Allergic Airway Disease
二氧化氮对过敏性气道疾病的敏感性
  • 批准号:
    7839235
  • 财政年份:
    2009
  • 资助金额:
    $ 23.86万
  • 项目类别:
Nitrogen Dioxide in the Sensitization to Allergic Airway Disease
二氧化氮对过敏性气道疾病的敏感性
  • 批准号:
    7808774
  • 财政年份:
    2007
  • 资助金额:
    $ 23.86万
  • 项目类别:
Nitrogen Dioxide in the Sensitization to Allergic Airway Disease
二氧化氮对过敏性气道疾病的敏感性
  • 批准号:
    7296585
  • 财政年份:
    2007
  • 资助金额:
    $ 23.86万
  • 项目类别:
MECHANISMS OF ALLERGIC SENSITIZATION BY NITROGEN DIOXIDE EXPOSURE
二氧化氮暴露引起过敏的机制
  • 批准号:
    7609698
  • 财政年份:
    2007
  • 资助金额:
    $ 23.86万
  • 项目类别:
Nitrogen Dioxide in the Sensitization to Allergic Airway Disease
二氧化氮对过敏性气道疾病的敏感性
  • 批准号:
    7474734
  • 财政年份:
    2007
  • 资助金额:
    $ 23.86万
  • 项目类别:

相似海外基金

Lung resident Treg suppression of Th2 resident memory T cells in allergic asthma
过敏性哮喘中肺常驻 Treg 对 Th2 常驻记忆 T 细胞的抑制
  • 批准号:
    10664599
  • 财政年份:
    2023
  • 资助金额:
    $ 23.86万
  • 项目类别:
Development of a highly sensitive and specific POCT testing asthma triggering allergic IgE
开发高度敏感和特异的 POCT 测试哮喘触发过敏性 IgE
  • 批准号:
    10600767
  • 财政年份:
    2023
  • 资助金额:
    $ 23.86万
  • 项目类别:
The effects of wildfire exposure on maternal allergic asthma and consequences on neurobiology
野火暴露对母亲过敏性哮喘的影响及其对神经生物学的影响
  • 批准号:
    10727122
  • 财政年份:
    2023
  • 资助金额:
    $ 23.86万
  • 项目类别:
Development of a highly sensitive and specific POCT testing asthma triggering allergic IgE
开发高度敏感和特异的 POCT 测试哮喘触发过敏性 IgE
  • 批准号:
    10817658
  • 财政年份:
    2023
  • 资助金额:
    $ 23.86万
  • 项目类别:
The Role of PON2 in the Development of Non-Allergic Asthma in Obesity
PON2 在肥胖引起的非过敏性哮喘发展中的作用
  • 批准号:
    10533862
  • 财政年份:
    2022
  • 资助金额:
    $ 23.86万
  • 项目类别:
Defining the development of tissue-resident memory Th2 cells in allergic asthma
定义过敏性哮喘中组织驻留记忆 Th2 细胞的发育
  • 批准号:
    10501568
  • 财政年份:
    2022
  • 资助金额:
    $ 23.86万
  • 项目类别:
Lipid shuttling in memory Th2 cell fate and function in allergic asthma
记忆中的脂质穿梭 过敏性哮喘中 Th2 细胞的命运和功能
  • 批准号:
    10572303
  • 财政年份:
    2022
  • 资助金额:
    $ 23.86万
  • 项目类别:
The Role of PON2 in the Development of Non-Allergic Asthma in Obesity
PON2 在肥胖引起的非过敏性哮喘发展中的作用
  • 批准号:
    10734050
  • 财政年份:
    2022
  • 资助金额:
    $ 23.86万
  • 项目类别:
Development of B cell memory in allergic asthma
过敏性哮喘中 B 细胞记忆的发展
  • 批准号:
    10503760
  • 财政年份:
    2022
  • 资助金额:
    $ 23.86万
  • 项目类别:
Break Down Barriers: Respiratory epithelial cells as modulators of dendritic cells during the pathogen associated allergic sensitization and acute asthma exacerbation
打破障碍:在病原体相关的过敏致敏和哮喘急性发作期间,呼吸道上皮细胞作为树突状细胞的调节剂
  • 批准号:
    504226880
  • 财政年份:
    2022
  • 资助金额:
    $ 23.86万
  • 项目类别:
    Research Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了